Loading…
Larimar Therapeutics, Inc. is projected to decline to $3.66 by 2027, a -4% move from its current price of $3.82. LRMR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $3.67 | $3.82 | $3.98 | 0.00% |
| Aug 4 | $3.61 | $3.82 | $4.04 | +0.01% |
| Aug 5 | $3.57 | $3.82 | $4.09 | +0.01% |
| Aug 6 | $3.53 | $3.82 | $4.14 | +0.02% |
| Aug 7 | $3.50 | $3.82 | $4.18 | +0.02% |
| Aug 8 | $3.47 | $3.82 | $4.21 | +0.02% |
| Aug 9 | $3.44 | $3.82 | $4.24 | +0.03% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.44 | $3.82 | $4.24 | +0.03% |
| Week 2 | $3.29 | $3.82 | $4.44 | +0.05% |
| Week 3 | $3.19 | $3.82 | $4.59 | +0.08% |
| Week 4 | $3.10 | $3.82 | $4.72 | +0.11% |
| Week 5 | $3.02 | $3.83 | $4.84 | +0.14% |
| Week 6 | $2.96 | $3.83 | $4.95 | +0.16% |
| Week 7 | $2.90 | $3.83 | $5.06 | +0.19% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal disease.
The company is based in Bala Cynwyd, Pennsylvania. It is categorized within Healthcare.
LRMR trades at a current price of $3.81 with a market capitalization of $395.79M. Its market rank is 3244. The stock sits amid a forecast that shows mixed near-term movement but potential long-term upside, with annual price paths and ROIs provided for each year.
In the near term, the 2026–2029 forecasts are neutral, then the outlook turns bullish from 2031 onward, with larger expected gains in 2040 and 2050. The projected average prices rise from the 2026 level toward substantially higher targets later in the horizon, reflecting the long-range growth implied by the model.
A major floor 34.9% below — a decisive break under it would weaken the trend.
The nearest floor, 20.2% below — buyers have tended to step in here.
The nearest ceiling, 12.0% above — a clean break opens room to run.
A major ceiling 33.2% above — clearing it would confirm fresh momentum.
Key LRMR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LRMR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.79 | Buy | $3.81 | Buy |
| MA 10 | $3.87 | Sell | $3.82 | Buy |
| MA 20 | $3.80 | Buy | $3.77 | Buy |
| MA 50 | $3.58 | Buy | $3.75 | Buy |
| MA 100 | $4.03 | Sell | $3.84 | Sell |
| MA 200 | $3.90 | Sell | $3.89 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.23 | Neutral |
| Stoch RSI (14) | 45.76 | Neutral |
| CCI (20) | 6.57 | Neutral |
| Williams %R (14) | -51.28 | Info |
| MACD (12,26,9) | -0.01 | Sell |
| ROC (12) | 0.26 | Buy |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 48.72 | Neutral |
| TRIX (15) | 0.34 | Buy |
| Awesome (5,34) | 0.12 | Buy |
| Ultimate (7,14,28) | 41.76 | Neutral |
| Momentum (10) | 0.12 | Buy |
| Aroon Osc (25) | 28.00 | Buy |
| Hull MA (9) | 3.71 | Buy |
| ADX (14) | 10.81 | Neutral |
| ATR (14) | 0.12 | Info |
The 30-day technical picture shows a bullish tilt in sentiment, with RSI(14) at 50. The SMA50 is $3.60 and the SMA200 is $3.94, indicating the short- to medium-term moving averages are roughly near the current price.
Support is identified at $3.05 and resistance at $4.28, suggesting a defined trading band around the current level. The 30-day price range spans from $2.73 to $5.32, illustrating notable near-term volatility. Annualized volatility is high at 100%, underscoring the potential for rapid price moves.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.81 | $3.82 | $5.14 | 0% | Neutral | |
| $2.80 | $3.66 | $5.13 | -4% | Neutral | |
| $2.77 | $3.78 | $5.58 | -1% | Neutral | |
| $2.83 | $4.01 | $6.15 | +5% | Neutral | |
| $3.19 | $4.66 | $7.39 | +22% | Bullish | |
| $4.00 | $6.03 | $9.84 | +58% | Bullish | |
| $3.75 | $5.82 | $9.73 | +52% | Bullish | |
| $3.47 | $5.53 | $9.46 | +45% | Bullish | |
| $3.85 | $6.28 | $10.98 | +64% | Bullish | |
| $3.43 | $5.73 | $10.21 | +50% | Bullish | |
| $4.80 | $9.00 | $17.36 | +136% | Bullish | |
| $7.47 | $16.60 | $35.87 | +334% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $2.81 | $3.82 | $4.65 | +0.00% |
| September 2026 | $3.10 | $3.71 | $4.61 | -2.82% |
| October 2026 | $3.17 | $3.83 | $4.83 | +3.26% |
| November 2026 | $3.30 | $4.03 | $5.14 | +5.03% |
| December 2026 | $3.24 | $3.98 | $5.14 | -1.08% |
Click any year to see its month-by-month LRMR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, LRMR could reach as high as $5.14, with a base case around $3.82 and support toward $2.81 — roughly 0% from $3.82. Price action looks broadly range-bound.
Expect LRMR to range from $2.80 to $5.13 through 2027. The $3.66 average target implies a -4% move from current prices. That is -4% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The LRMR price prediction for 2028 points to an average of $3.78 (low $2.77, high $5.58) — a potential decline of -1% on today's $3.82. Price action looks broadly range-bound.
In 2029, LRMR is projected to trade between $2.83 and $6.15, averaging $4.01 — a potential gain of +5% from today's $3.82. That is up +6% on the projected 2028 average. A consolidation phase looks the most probable path here.
Larimar Therapeutics, Inc.'s 2030 outlook centres on $4.66, within a $3.19 to $7.39 range. That is up +16% on the projected 2029 average. That marks a +22% change versus current levels. Momentum favours further upside here.
By 2031, LRMR could reach as high as $9.84, with a base case around $6.03 and support toward $4.00 — roughly +58% from $3.82. Buyers look set to stay in control over this stretch.
Expect LRMR to range from $3.75 to $9.73 through 2032. The $5.82 average target implies a +52% move from current prices. That is -4% versus the projected 2031 average. Momentum favours further upside here.
The LRMR price prediction for 2033 points to an average of $5.53 (low $3.47, high $9.46) — a potential gain of +45% on today's $3.82. Buyers look set to stay in control over this stretch.
In 2034, LRMR is projected to trade between $3.85 and $10.98, averaging $6.28 — a potential gain of +64% from today's $3.82. That is up +14% on the projected 2033 average. Momentum favours further upside here.
Larimar Therapeutics, Inc.'s 2035 outlook centres on $5.73, within a $3.43 to $10.21 range. That is -9% versus the projected 2034 average. That marks a +50% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, LRMR could reach as high as $17.36, with a base case around $9.00 and support toward $4.80 — roughly +136% from $3.82. Momentum favours further upside here.
Expect LRMR to range from $7.47 to $35.87 through 2050. The $16.60 average target implies a +334% move from current prices. That is up +84% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in LRMR today (≈ 261.780105 LRMR) could be worth
$4,344.48
+$3,344.48 (+334%) by 2050 · US Dollar
Based on the average projected LRMR price of $16.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LRMRwould be worth at today's price.
$1,000 invested in LRMR on Jul 31, 2025 (≈ 289.017338 LRMR) would be worth
$1,104.05
+$104.05 (+10.4%) today · 1.10× · US Dollar
Based on a LRMR entry price of $3.46 vs. today's $3.82.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4 | $955 | -4.5% |
| 1 month ago | $3.21 | $1,190.03 | +19.0% |
| 3 months ago | $3.94 | $969.54 | -3.0% |
| 6 months ago | $3.51 | $1,088.32 | +8.8% |
| 1 year ago | $3.46 | $1,104.05 | +10.4% |
| All time (5.0y) ago | $10 | $382 | -61.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LRMR forecast.
Our base-case forecast reaches $7.60 around 2040.
Implied market cap at $7.60: $789.51M
Looking across the multi-year forecast, 2030 is seen with an average price of $4.42 and a 16.1% ROI. The sentiment for 2030 remains NEUTRAL, with a longer horizon improving to a bullish stance from 2031 onward.
In 2031 the average is projected at $5.70 with a 49.7% ROI, and 2032–2035 continue to show bullish momentum with higher averages and robust ROIs (2032 avg $5.33, ROI 39.9%; 2033 avg $5.17, ROI 35.7%; 2034 avg $5.75, ROI 50.9%; 2035 avg $4.82, ROI 26.4%).
The arc of the forecast rises more markedly by 2040, with an average of $7.97 and ROI of 109.3%. By 2050, the average is $14.20 with a ROI of 272.6%, and sentiment remains BULLISH. These levels reflect a path of substantial longer-term upside, balanced by near-term uncertainty.
Tap a question to reveal the answer.
2030 min $2.80, avg $4.42, max $7.54; ROI 16.1%; sentiment NEUTRAL.
Near-term forecasts (2026–2029) show NEUTRAL sentiment with average prices around $3.81 in 2026, $3.55 in 2027, $3.42 in 2028, and $3.58 in 2029. Long-term, the outlook turns bullish from 2031 onward, with average prices rising to $5.70 (2031) and up to $14.20 by 2050, and ROIs reaching 49.7% (2031) and 272.6% (2050). These are estimates and not guarantees.
Yes. The forecast shows a 2031 max of $10.05, with an average of $5.70 and a min of $3.46.
The 30-day range is $2.73 to $5.32, current price is $3.81, with support at $3.05 and resistance at $4.28. RSI(14) is 50, SMA50 is $3.60, SMA200 is $3.94, and annualized volatility is 100%.
Current price is $3.81. Market capitalization is $395.79M, and the rank is 3244.
Larimar Therapeutics, Inc. Community Discussion
0Share your Larimar Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.